Urology
Volume 72, Issue 6 , Pages 1274-1279 , December 2008

Determinants of Treatment Regret in Low-Income, Uninsured Men With Prostate Cancer

  • Jim C. Hu

      Affiliations

    • Division of Urology, Brigham and Women's Hospital, Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationReprint requests: Jim C. Hu, M.D., M.P.H., Division of Urology, Brigham and Women's Hospital, Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, 45 Francis Street, ASBII-3, Boston, MA 02115
    • ,
  • Lorna Kwan

      Affiliations

    • Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California
    • ,
  • Tracey L. Krupski

      Affiliations

    • Division of Urology, Duke University Medical School, Durham, North Carolina
    • ,
  • Jennifer T. Anger

      Affiliations

    • Department of Urology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California
    • Department of and Health Services, University of California, Los Angeles, School of Public Health, Los Angeles, California
    • ,
  • Sally L. Maliski

      Affiliations

    • Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California
    • ,
  • Sarah Connor

      Affiliations

    • Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California
    • ,
  • Mark S. Litwin

      Affiliations

    • Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California
    • Department of Urology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California
    • Department of and Health Services, University of California, Los Angeles, School of Public Health, Los Angeles, California

Received 9 November 2006 ,Accepted 12 November 2007.

References 

  1. Clark JA, Wray NP, Ashton CM. Living with treatment decisions: regrets and quality of life among men treated for metastatic prostate cancer. J Clin Oncol. 2001;19:72–80
  2. Hu JC, Kwan L, Saigal CS, et al. Regret in men treated for localized prostate cancer. J Urol. 2003;169:2279–2283
  3. Pascoe GC. Patient satisfaction in primary health care: a literature review and analysis. Eval Program Plann. 1983;6:185–210
  4. Bell D. Regret in decision-making under uncertainty. Operations Res. 1982;30:961–981
  5. Miles BJ, Giesler B, Kattan MW. Recall and attitudes in patients with prostate cancer. Urology. 1999;53:169–174
  6. McCammon KA, Kolm P, Main B, et al. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology. 1999;54:509–516
  7. Roth AJ, Kornblith AB, Batel-Copel L, et al. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer. 1998;82:1904–1908
  8. Lubeck DP, Kim H, Grossfeld G, et al. Health related quality of life differences between black and white men with prostate cancer: data from the Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol. 2001;166:2281–2285
  9. Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA. 2000;283:354–360
  10. Lubeck DP, Litwin MS, Henning JM, et al. Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. Urology. 1999;53:180–186
  11. Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233
  12. Litwin MS, Hays RD, Fink A, et al. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36:1002–1012
  13. Peterman AH, Fitchett G, Brady MJ, et al. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy—Spiritual Well-Being Scale (FACIT-Sp). Ann Behav Med. 2002;24:49–58
  14. Dale W, Hemmerich J, Meltzer D. Extending the validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) at the time of prostate biopsy in a racially-mixed population. Psychooncology. 2007;16:493–498
  15. Roth A, Nelson CJ, Rosenfeld B, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics. 2006;47:340–347
  16. Mehta SS, Lubeck DP, Pasta DJ, et al. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE. J Urol. 2003;170:1931–1933
  17. Brady MJ, Peterman AH, Fitchett G, et al. A case for including spirituality in quality of life measurement in oncology. Psychooncology. 1999;8:417–428
  18. Pettingale KW, Morris T, Greer S, et al. Mental attitudes to cancer: an additional prognostic factor. Lancet. 1985;1:
  19. Herr HW. Quality of life of incontinent men after radical prostatectomy. J Urol. 1994;151:652–654
  20. Holmboe ES, Concato J. Treatment decisions for localized prostate cancer: asking men what's important. J Gen Intern Med. 2000;15:694–701
  21. Hall JD, Boyd JC, Lippert MC, et al. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey. Urology. 2003;61:402–407
  22. Clark JA, Talcott JA. Confidence and uncertainty long after initial treatment for early prostate cancer: survivors' views of cancer control and the treatment decisions they made. J Clin Oncol. 2006;24:4457–4463
  23. Wilt TJ. Uncertainty in prostate cancer care: the physician's role in clearing the confusion. JAMA. 2000;283:3258–3260
  24. Saha S, Komaromy M, Koepsell TD, et al. Patient-physician racial concordance and the perceived quality and use of health care. Arch Intern Med. 1999;159:997–1004
  25. Ullrich PM, Carson MR, Lutgendorf SK, et al. Cancer fear and mood disturbance after radical prostatectomy: consequences of biochemical evidence of recurrence. J Urol. 2003;169:1449–1452

 This study was supported by an award from the California Department of Health Services Cancer Detection Section.

 The analysis, interpretations, and conclusions presented in this report are those of the authors and not the State of California.

PII: S0090-4295(07)02447-8

doi: 10.1016/j.urology.2007.11.066

Urology
Volume 72, Issue 6 , Pages 1274-1279 , December 2008

Article Tools